Trial · NCT01974141
Results by group26
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 26
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Patients With a Score of 0 (None) or 1 (Minimal) on the 5-point Global Acne Assessment Score (GAAS) | Dapsone Gel | 29.9 | Percentage of Patients | ||
| Percentage of Patients With a Score of 0 (None) or 1 (Minimal) on the 5-point Global Acne Assessment Score (GAAS) | Dapsone Gel Vehicle | 21.2 | Percentage of Patients | ||
| Change From Baseline in Inflammatory Facial Lesion Counts | Dapsone Gel | Baseline | 29.0 | Standard Error 0.25 | Number of Inflammatory Lesions |
| Change From Baseline in Inflammatory Facial Lesion Counts | Dapsone Gel Vehicle | Baseline | 29.4 | Standard Error 0.25 | Number of Inflammatory Lesions |
| Change From Baseline in Inflammatory Facial Lesion Counts | Dapsone Gel | Change from Baseline at Week 12 | -16.1 | Standard Error 0.32 | Number of Inflammatory Lesions |
| Change From Baseline in Inflammatory Facial Lesion Counts | Dapsone Gel Vehicle | Change from Baseline at Week 12 | -14.1 | Standard Error 0.32 | Number of Inflammatory Lesions |
| Change From Baseline in Noninflammatory Facial Lesion Counts | Dapsone Gel | Baseline | 47.0 | Standard Error 0.53 | Number of Noninflammatory Lesions |
| Change From Baseline in Noninflammatory Facial Lesion Counts | Dapsone Gel Vehicle | Baseline | 48.7 | Standard Error 0.53 | Number of Noninflammatory Lesions |
| Change From Baseline in Noninflammatory Facial Lesion Counts | Dapsone Gel | Change from Baseline at Week 12 | -20.8 | Standard Error 0.56 | Number of Noninflammatory Lesions |
| Change From Baseline in Noninflammatory Facial Lesion Counts | Dapsone Gel Vehicle | Change from Baseline at Week 12 | -17.6 | Standard Error 0.55 | Number of Noninflammatory Lesions |
| Change From Baseline in Total Lesion Counts | Dapsone Gel | Baseline | 75.9 | Standard Error 0.65 | Total Lesion Counts |
| Change From Baseline in Total Lesion Counts | Dapsone Gel Vehicle | Baseline | 78.1 | Standard Error 0.65 | Total Lesion Counts |
| Change From Baseline in Total Lesion Counts | Dapsone Gel | Change from Baseline at Week 12 | -36.9 | Standard Error 0.76 | Total Lesion Counts |
| Change From Baseline in Total Lesion Counts | Dapsone Gel Vehicle | Change from Baseline at Week 12 | -31.7 | Standard Error 0.75 | Total Lesion Counts |
| Percentage Change From Baseline in Total Lesion Counts | Dapsone Gel | -48.7 | Standard Error 0.95 | Percent Change in Lesion Count | |
| Percentage Change From Baseline in Total Lesion Counts | Dapsone Gel Vehicle | -42.4 | Standard Error 0.93 | Percent Change in Lesion Count | |
| Percentage of Patients Reporting Very Good or Excellent on Item 10 of the 5-Point Acne Symptom Impact Scale (ASIS) | Dapsone Gel | 23.8 | Percentage of Patients | ||
| Percentage of Patients Reporting Very Good or Excellent on Item 10 of the 5-Point Acne Symptom Impact Scale (ASIS) | Dapsone Gel Vehicle | 19.2 | Percentage of Patients | ||
| Change From Baseline in the 9-Item ASIS Sign Domain Score | Dapsone Gel | Baseline | 4.2 | Standard Deviation 0.69 | Scores on a Scale |
| Change From Baseline in the 9-Item ASIS Sign Domain Score | Dapsone Gel Vehicle | Baseline | 4.2 | Standard Deviation 0.71 | Scores on a Scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01974141/results